Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
CTD Announces Appointment of Sharon H. Hrynkow, PhD as Chief Scientific Officer | ||
By: Nasdaq / GlobeNewswire - 15 Feb 2019 | Back to overview list |
|
ALACHUA, Fla., Feb. 15, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, announced today the appointment of Sharon H. Hrynkow, PhD, the company’s Senior Vice President for Medical Affairs, as Chief Scientific Officer. “Dr. Hrynkow will continue to strengthen the company’s clinical pipeline and research programs, while supporting our business development activities. She will also continue to oversee our regulatory and medical affairs work as she takes on this new role,” said N. Scott Fine, CTD Chairman and CEO. “The Board looks forward to working with Dr. Hrynkow in this new capacity.” Mr. Fine continued, “On behalf of the Board and to our fellow Board member, we are very grateful to Dr. Jeffrey Tate, COO, for his work as CSO over the past years. This transition will allow Dr. Tate to focus on our growing global operation as we expand our company’s platform.” Dr. Hrynkow, a neuroscientist by training, joined CTD in 2015 to develop the company’s clinical program for Trappsol® Cyclo™, its proprietary formulation of hydroxypropyl beta cyclodextrin used in the treatment of Niemann-Pick Disease Type C (NPC). Today, CTD supports two formal clinical trials for the NPC indication and one extension protocol. CTD also supports compassionate programs in NPC and in late onset Alzheimer’s Disease. About CTD Holdings: Safe Harbor Statement: Investor/Media Contact: |
||
|
||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |